TAZOFORT

This brand name is authorized in Nigeria.

Active ingredients

The drug TAZOFORT contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7259	Tablet	Tazofort Tablets TAB 500 mg 1 x 10's (in Alu-Alu blister)	Tablet TAZOFORT TABLETS "CEFUROXIME AXETIL USP EP.CEFUROXIME 500MG MICROCRYSTALLINE CELLULOSE,CROSPOVIDONE, PURIFIED TALC, SODIUM BI CARBONATE,CITRIC ACID, MONOHYDRATE, SODIUM LAURYL SULPHATE, COLLOIDAL ANHYDROUS SILICA,HYDROXY PROPYL METHYL CELLULOSE,ISOPROPYL ALCOHOL, DICHLOROBENZENE AND TITANIUM DIOXIDE." B4-7259 Drugs Imported Product 1X10 12-08-2024 CHINARE ANI PHARMACEUTICALS LTD, 55, ISHOKUN-ODO STREET, OWO, owo, , ONDO 08037950951 chinareani528@gmail.com "PROTECH BIOSYSTEMS PVT. LTD.,, KHASRA NO. 251,252, SISONA-BHAGWANPUR, ROORKEE, DIST.- HARIDWAR, UTTARAKHAND INDIA"	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7259